JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

JNJ

165.9

-1.41%↓

NVS

116.08

-1.28%↓

ABT

126.22

-0.29%↓

MDT

91.91

-1.07%↓

ELV.US

285.7

-1.24%↓

Search

Essa Pharma Inc

Cerrado

1.87

Resumen

Variación precio

24h

Actual

Mínimo

1.87

Máximo

1.87

Métricas clave

By Trading Economics

Ingresos

2.2M

-6.4M

BPA

-0.14

Empleados

35

EBITDA

-2.2M

-8.5M

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

7.1M

83M

Apertura anterior

1.87

Cierre anterior

1.87

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Essa Pharma Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

28 jul 2025, 21:15 UTC

Ganancias

Waste Management 2Q Profit and Sales Rise, Cuts Fiscal Year Sales Outlook

28 jul 2025, 23:48 UTC

Adquisiciones, fusiones, absorciones

Berkshire Hathaway Selling Part of Verisign Stake; Stock Falling After-Hours -- Barrons.com

28 jul 2025, 23:46 UTC

Charlas de Mercado

Nikkei May Trade in Range Amid Uncertainty over Earnings -- Market Talk

28 jul 2025, 23:42 UTC

Ganancias

Keppel Pacific Oak US REIT: Property Expenses Rose on Year >CMOU.SG

28 jul 2025, 23:42 UTC

Charlas de Mercado

Gold Consolidates; Trade-Deal Hopes May Weigh -- Market Talk

28 jul 2025, 23:41 UTC

Ganancias

Keppel Pacific Oak US REIT 1H Income Available for Distribution $19.9M Vs. $23.8M >CMOU.SG

28 jul 2025, 23:40 UTC

Ganancias

Keppel Pacific Oak US REIT 1H Net Property Income $40.7M Vs. $42.0M >CMOU.SG

28 jul 2025, 23:40 UTC

Ganancias

Keppel Pacific Oak US REIT 1H Gross Rev $74.6M Vs. $74.4M >CMOU.SG

28 jul 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Woodside: Development Wells in Bass Strait Could Deliver Up to 200 PJ of Gas for Sale

28 jul 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Woodside Identifies 4 Potential Development Wells in Bass Strait

28 jul 2025, 23:35 UTC

Adquisiciones, fusiones, absorciones

Woodside Expects More Than US$60 Million of Savings From Bass Strait Operatorship

28 jul 2025, 23:34 UTC

Adquisiciones, fusiones, absorciones

Woodside to Pursue Strategy that Targets Further Output, Reliability Improvements in Bass Strait

28 jul 2025, 23:34 UTC

Adquisiciones, fusiones, absorciones

Woodside to Have Responsibility for Asset Planning, Execution Activities

28 jul 2025, 23:33 UTC

Adquisiciones, fusiones, absorciones

Woodside, Exxon Mobil's Equity Interests in Bass Strait Assets Unchanged

28 jul 2025, 23:32 UTC

Adquisiciones, fusiones, absorciones

Woodside Energy Expects to Complete Deal With Exxon Mobil in 2026

28 jul 2025, 23:32 UTC

Adquisiciones, fusiones, absorciones

Woodside Energy Agrees to Become Operator of Bass Strait Assets

28 jul 2025, 22:46 UTC

Charlas de Mercado

AIC Mines Bull Surprised by Capex Growth -- Market Talk

28 jul 2025, 22:29 UTC

Ganancias

Sandfire Resources to Provide FY26 Cost Guidance Alongside FY Results

28 jul 2025, 22:28 UTC

Ganancias

Sandfire Resources Expects FY26 Copper Eq Output of 149,000-165,000 Tons

28 jul 2025, 22:27 UTC

Ganancias

Sandfire Resources Net Debt US$123 Million at June 30

28 jul 2025, 22:27 UTC

Ganancias

Sandfire Resources FY Unaudited Underlying Ebitda US$528 Million

28 jul 2025, 22:26 UTC

Ganancias

Sandfire Resources FY Unaudited Sales Revenue US$1.18 Billion

28 jul 2025, 22:26 UTC

Ganancias

Sandfire Resources FY Motheo Underlying Operating Unit Cost US$40/Ton

28 jul 2025, 22:25 UTC

Ganancias

Sandfire Resources FY Matsa Underlying Operating Unit Cost US$78/Ton

28 jul 2025, 22:24 UTC

Ganancias

Sandfire Resources FY Copper Eq Output 152,400 Tons, Up 12% On-Year

28 jul 2025, 21:35 UTC

Ganancias

Lululemon Stock Has Rebounded. What to Expect From Earnings. -- Barrons.com

28 jul 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

LVMH-Backed L Catterton Strikes $200 Million Deal for L.A.B. Golf, Sources Say -- WSJ

28 jul 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

LVMH-Backed L Catterton to Buy Majority Stake After L.A.B. Golf's Putter Used to Win U.S. Open, Sources Say -- WSJ

28 jul 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

Private-Equity Firm L Catterton Strikes $200 Million Deal for L.A.B. Golf, Sources Say -- WSJ

28 jul 2025, 21:00 UTC

Ganancias

Waste Management 2Q Profit and Sales Rise, Cuts FY Sales Outlook

Comparación entre iguales

Cambio de precio

Essa Pharma Inc Esperado

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

1.7 / 1.72Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.